» Articles » PMID: 25894416

The Incremental Risk of Coronary Stents on Postoperative Adverse Events: A Matched Cohort Study

Overview
Journal Ann Surg
Specialty General Surgery
Date 2015 Apr 21
PMID 25894416
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the incremental risk of coronary stents on adverse events in surgical patients and whether it varies over time from stent placement.

Background: Postoperative adverse cardiac events decrease as the time from stent placement increases, but the risk attributable to the stent versus the underlying cardiac disease is uncertain, as prior studies lack a control surgical population.

Methods: Data for patients with coronary stents implanted in a VA hospital from 2000 to 2010 were matched with VA Surgical Quality Improvement Program data to identify noncardiac surgery within 24 months of stent placement. Each patient with stent was matched with 2 surgical patients without stent on surgical characteristics and cardiac risk factors. Outcomes of myocardial infarction (MI), revascularization, and death within 30 days after surgery were modeled using logistic regression. Adjusted risk differences between stented and nonstented populations were compared across time after stent placement.

Results: Adverse cardiac events followed surgery in 531 (5.7%) of the 9391 patients with stent and 680 (3.6%) of the 18,782 patients without stent (P < 0.001). In adjusted models, 30-day postoperative MI (odds ratio = 1.90; 95% confidence interval, 1.57-2.30) and revascularization (odds ratio = 2.03; 95% confidence interval, 1.65-2.50) but not mortality (odds ratio = 0.84; 95% confidence interval, 0.69-1.02) were higher in the stented cohort. Assessing trends over the 2 years after stent placement, the incremental risk for MI decreased from 5% immediately after stent placement to 2% at 1 year and then was no longer significantly elevated. The incremental risk did not vary by stent type.

Conclusions: Surgery after coronary stent placement is associated with an approximate 2% absolute risk for postoperative MI but no difference in mortality compared with nonstented matched controls.

Citing Articles

International Digestive Endoscopy Network Consensus on the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy.

Kang S, Tae C, Bang C, Shin C, Jeong Y, Choi M Gut Liver. 2024; 18(5):764-780.

PMID: 39223080 PMC: 11391130. DOI: 10.5009/gnl240176.


Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial.

Wang B, Su Y, Ma C, Xu L, Mao Q, Cheng W BMC Med. 2024; 22(1):171.

PMID: 38649992 PMC: 11036782. DOI: 10.1186/s12916-024-03391-2.


International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy.

Kang S, Tae C, Bang C, Shin C, Jeong Y, Choi M Clin Endosc. 2024; 57(2):141-157.

PMID: 38556472 PMC: 10984749. DOI: 10.5946/ce.2024.002.


Assessment of the prognostic value of preoperative high-sensitive troponin T for myocardial injury and long-term mortality for groups at high risk for cardiovascular events following noncardiac surgery: a retrospective cohort study.

Zhu Y, Bi Y, Yu Q, Liu B Front Med (Lausanne). 2023; 10:1135786.

PMID: 37425305 PMC: 10325788. DOI: 10.3389/fmed.2023.1135786.


Update of the Brazilian Society of Cardiology's Perioperative Cardiovascular Assessment Guideline: Focus on Managing Patients with Percutaneous Coronary Intervention - 2022.

Calderaro D, Bichuette L, Maciel P, Cardozo F, Barbosa Ribeiro H, Gualandro D Arq Bras Cardiol. 2022; 118(2):536-547.

PMID: 35262593 PMC: 8856674. DOI: 10.36660/abc.20220039.